Percutaneous treatment of symptomatic central venous stenosis angioplasty

Larry Richard Sprouse, Christopher J. Lesar, George H. Meier, F. Noel Parent, Richard J. Demasi, Robert G. Gayle, Michael J. Marcinzyck, Marc H. Glickman, Raseh M. Shah, C. Scott McEnroe, Martin A. Fogle, Gordon K. Stokes, John O. Colonna

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Objectives: The increased use of central venous access primarily for hemodialysis has led to a significant increase in clinically relevant central venous occlusive disease (CVOD). The magnitude of and the optimal therapy for CVOD are not clearly established. The purpose of this study is to define the problem of CVOD and determine the success of percutaneous therapy for relieving symptoms and maintaining central venous patency. Methods: Patients presenting with disabling upper-extremity edema suggestive of central venous stenosis or occlusion during a 3-year period were evaluated by venography of the upper extremity and central veins. Percutaneous venous angioplasty (PTA) and/or stent placement was performed as clinically indicated. The success of therapy was assessed, and the patients were observed to determine the incidence of recurrence and additional procedures. Recurrent lesions underwent similar evaluation and treatment. Results: A total of 32 sides were treated in 29 patients with a mean of 1.9 interventions per side treated. Hemodialysis-related lesions were the underlying cause in 87% with the remaining 13% related to previous central venous catheterization. The lesions involved the axillary, subclavian, and innominate veins with complete venous occlusion in six (19%) cases. Percutaneous angioplasty was followed by stent placement in six (19%) cases. The procedure was a technical success and was performed without complications in all cases (100%). Mean follow-up was 16.5 months (range, 4-36 months). On average, patient symptoms were controlled for 6.5 months after the initial intervention. Recurrent edema led to additional PTA in 20 (63%) cases. Fifty percent (n = 14) of patients with an arteriovenous fistula (AVF) experienced recurrent symptoms after initial and/or repeat PTA and required AVF ligation. Complete resolution after the initial PTA was predictive of long-term success. Conclusions: Central venous occlusive disease has emerged as a significant clinical problem. Percutaneous venous angioplasty can provide temporary symptomatic relief; however, multiple procedures are often required and long-term relief is rarely achieved.

Original languageEnglish (US)
Pages (from-to)578-582
Number of pages5
JournalJournal of Vascular Surgery
Volume39
Issue number3
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Angioplasty
Pathologic Constriction
Arteriovenous Fistula
Upper Extremity
Stents
Renal Dialysis
Edema
Therapeutics
Axillary Vein
Brachiocephalic Veins
Central Venous Catheterization
Subclavian Vein
Phlebography
Ligation
Veins
Recurrence
Incidence

All Science Journal Classification (ASJC) codes

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Sprouse, L. R., Lesar, C. J., Meier, G. H., Parent, F. N., Demasi, R. J., Gayle, R. G., ... Colonna, J. O. (2004). Percutaneous treatment of symptomatic central venous stenosis angioplasty. Journal of Vascular Surgery, 39(3), 578-582. https://doi.org/10.1016/j.jvs.2003.09.034

Percutaneous treatment of symptomatic central venous stenosis angioplasty. / Sprouse, Larry Richard; Lesar, Christopher J.; Meier, George H.; Parent, F. Noel; Demasi, Richard J.; Gayle, Robert G.; Marcinzyck, Michael J.; Glickman, Marc H.; Shah, Raseh M.; McEnroe, C. Scott; Fogle, Martin A.; Stokes, Gordon K.; Colonna, John O.

In: Journal of Vascular Surgery, Vol. 39, No. 3, 01.01.2004, p. 578-582.

Research output: Contribution to journalArticle

Sprouse, LR, Lesar, CJ, Meier, GH, Parent, FN, Demasi, RJ, Gayle, RG, Marcinzyck, MJ, Glickman, MH, Shah, RM, McEnroe, CS, Fogle, MA, Stokes, GK & Colonna, JO 2004, 'Percutaneous treatment of symptomatic central venous stenosis angioplasty', Journal of Vascular Surgery, vol. 39, no. 3, pp. 578-582. https://doi.org/10.1016/j.jvs.2003.09.034
Sprouse, Larry Richard ; Lesar, Christopher J. ; Meier, George H. ; Parent, F. Noel ; Demasi, Richard J. ; Gayle, Robert G. ; Marcinzyck, Michael J. ; Glickman, Marc H. ; Shah, Raseh M. ; McEnroe, C. Scott ; Fogle, Martin A. ; Stokes, Gordon K. ; Colonna, John O. / Percutaneous treatment of symptomatic central venous stenosis angioplasty. In: Journal of Vascular Surgery. 2004 ; Vol. 39, No. 3. pp. 578-582.
@article{fcaf8b4bb1b8454e830f6c5d8df324bd,
title = "Percutaneous treatment of symptomatic central venous stenosis angioplasty",
abstract = "Objectives: The increased use of central venous access primarily for hemodialysis has led to a significant increase in clinically relevant central venous occlusive disease (CVOD). The magnitude of and the optimal therapy for CVOD are not clearly established. The purpose of this study is to define the problem of CVOD and determine the success of percutaneous therapy for relieving symptoms and maintaining central venous patency. Methods: Patients presenting with disabling upper-extremity edema suggestive of central venous stenosis or occlusion during a 3-year period were evaluated by venography of the upper extremity and central veins. Percutaneous venous angioplasty (PTA) and/or stent placement was performed as clinically indicated. The success of therapy was assessed, and the patients were observed to determine the incidence of recurrence and additional procedures. Recurrent lesions underwent similar evaluation and treatment. Results: A total of 32 sides were treated in 29 patients with a mean of 1.9 interventions per side treated. Hemodialysis-related lesions were the underlying cause in 87{\%} with the remaining 13{\%} related to previous central venous catheterization. The lesions involved the axillary, subclavian, and innominate veins with complete venous occlusion in six (19{\%}) cases. Percutaneous angioplasty was followed by stent placement in six (19{\%}) cases. The procedure was a technical success and was performed without complications in all cases (100{\%}). Mean follow-up was 16.5 months (range, 4-36 months). On average, patient symptoms were controlled for 6.5 months after the initial intervention. Recurrent edema led to additional PTA in 20 (63{\%}) cases. Fifty percent (n = 14) of patients with an arteriovenous fistula (AVF) experienced recurrent symptoms after initial and/or repeat PTA and required AVF ligation. Complete resolution after the initial PTA was predictive of long-term success. Conclusions: Central venous occlusive disease has emerged as a significant clinical problem. Percutaneous venous angioplasty can provide temporary symptomatic relief; however, multiple procedures are often required and long-term relief is rarely achieved.",
author = "Sprouse, {Larry Richard} and Lesar, {Christopher J.} and Meier, {George H.} and Parent, {F. Noel} and Demasi, {Richard J.} and Gayle, {Robert G.} and Marcinzyck, {Michael J.} and Glickman, {Marc H.} and Shah, {Raseh M.} and McEnroe, {C. Scott} and Fogle, {Martin A.} and Stokes, {Gordon K.} and Colonna, {John O.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/j.jvs.2003.09.034",
language = "English (US)",
volume = "39",
pages = "578--582",
journal = "Journal of Vascular Surgery",
issn = "0741-5214",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Percutaneous treatment of symptomatic central venous stenosis angioplasty

AU - Sprouse, Larry Richard

AU - Lesar, Christopher J.

AU - Meier, George H.

AU - Parent, F. Noel

AU - Demasi, Richard J.

AU - Gayle, Robert G.

AU - Marcinzyck, Michael J.

AU - Glickman, Marc H.

AU - Shah, Raseh M.

AU - McEnroe, C. Scott

AU - Fogle, Martin A.

AU - Stokes, Gordon K.

AU - Colonna, John O.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Objectives: The increased use of central venous access primarily for hemodialysis has led to a significant increase in clinically relevant central venous occlusive disease (CVOD). The magnitude of and the optimal therapy for CVOD are not clearly established. The purpose of this study is to define the problem of CVOD and determine the success of percutaneous therapy for relieving symptoms and maintaining central venous patency. Methods: Patients presenting with disabling upper-extremity edema suggestive of central venous stenosis or occlusion during a 3-year period were evaluated by venography of the upper extremity and central veins. Percutaneous venous angioplasty (PTA) and/or stent placement was performed as clinically indicated. The success of therapy was assessed, and the patients were observed to determine the incidence of recurrence and additional procedures. Recurrent lesions underwent similar evaluation and treatment. Results: A total of 32 sides were treated in 29 patients with a mean of 1.9 interventions per side treated. Hemodialysis-related lesions were the underlying cause in 87% with the remaining 13% related to previous central venous catheterization. The lesions involved the axillary, subclavian, and innominate veins with complete venous occlusion in six (19%) cases. Percutaneous angioplasty was followed by stent placement in six (19%) cases. The procedure was a technical success and was performed without complications in all cases (100%). Mean follow-up was 16.5 months (range, 4-36 months). On average, patient symptoms were controlled for 6.5 months after the initial intervention. Recurrent edema led to additional PTA in 20 (63%) cases. Fifty percent (n = 14) of patients with an arteriovenous fistula (AVF) experienced recurrent symptoms after initial and/or repeat PTA and required AVF ligation. Complete resolution after the initial PTA was predictive of long-term success. Conclusions: Central venous occlusive disease has emerged as a significant clinical problem. Percutaneous venous angioplasty can provide temporary symptomatic relief; however, multiple procedures are often required and long-term relief is rarely achieved.

AB - Objectives: The increased use of central venous access primarily for hemodialysis has led to a significant increase in clinically relevant central venous occlusive disease (CVOD). The magnitude of and the optimal therapy for CVOD are not clearly established. The purpose of this study is to define the problem of CVOD and determine the success of percutaneous therapy for relieving symptoms and maintaining central venous patency. Methods: Patients presenting with disabling upper-extremity edema suggestive of central venous stenosis or occlusion during a 3-year period were evaluated by venography of the upper extremity and central veins. Percutaneous venous angioplasty (PTA) and/or stent placement was performed as clinically indicated. The success of therapy was assessed, and the patients were observed to determine the incidence of recurrence and additional procedures. Recurrent lesions underwent similar evaluation and treatment. Results: A total of 32 sides were treated in 29 patients with a mean of 1.9 interventions per side treated. Hemodialysis-related lesions were the underlying cause in 87% with the remaining 13% related to previous central venous catheterization. The lesions involved the axillary, subclavian, and innominate veins with complete venous occlusion in six (19%) cases. Percutaneous angioplasty was followed by stent placement in six (19%) cases. The procedure was a technical success and was performed without complications in all cases (100%). Mean follow-up was 16.5 months (range, 4-36 months). On average, patient symptoms were controlled for 6.5 months after the initial intervention. Recurrent edema led to additional PTA in 20 (63%) cases. Fifty percent (n = 14) of patients with an arteriovenous fistula (AVF) experienced recurrent symptoms after initial and/or repeat PTA and required AVF ligation. Complete resolution after the initial PTA was predictive of long-term success. Conclusions: Central venous occlusive disease has emerged as a significant clinical problem. Percutaneous venous angioplasty can provide temporary symptomatic relief; however, multiple procedures are often required and long-term relief is rarely achieved.

UR - http://www.scopus.com/inward/record.url?scp=10744222844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744222844&partnerID=8YFLogxK

U2 - 10.1016/j.jvs.2003.09.034

DO - 10.1016/j.jvs.2003.09.034

M3 - Article

VL - 39

SP - 578

EP - 582

JO - Journal of Vascular Surgery

JF - Journal of Vascular Surgery

SN - 0741-5214

IS - 3

ER -